191 / 232
Notes to the
Financial Statements
As at 31 March 2019
38. Financial instruments (cont’d.)
(a) Fair value measurement (cont’d.)
The following table presents the Group’s and the Company’s assets that are measured at fair value as at
31 March 2019 and 2018 respectively.
Group
Company
Date of
Level 1
Level 1
valuation
RM’000
RM’000
As at 31 March 2019
Assets disclosed at fair value:
Short term cash investments
31 March 2019
148,122
-
As at 31 March 2018
Assets disclosed at fair value:
Short term cash investments
31 March 2018
51,886
8,003
Group
Company
Date of
Level 3
Level 3
valuation
RM’000
RM’000
As at 31 March 2019
Assets disclosed at fair value:
Investment properties (Note 14)
31 March 2019
80,130
3,830
Assets measured at fair value:
Biological asset (Note 15)
31 March 2019
4,504
-
As at 31 March 2018
Assets disclosed at fair value:
Investment properties (Note 14)
31 March 2018
77,515
3,830
Assets measured at fair value:
Biological asset (Note 15)
31 March 2018
5,102
-
financial
statements
187